Lorena Napolitano Email

Head Product Research and Development . VitriVax

Current Roles

Employees:
34
Revenue:
$5.3M
About
VitriVax is commercializing a vaccine formulation platform enabling thermostability, and combined doses with timed release, for virtually any injectable vaccine. Our proprietary technology, created at the University of Colorado in Boulder with the support of over $5M from NIH, NSF and the State of Colorado, and most recently, $2.2M from the Bill and Melinda Gates Foundation, makes human and animal vaccines more effective, more affordable, and more accessible globally.
VitriVax Address
5435 Airport Boulevard
Boulder, CO
United States
VitriVax Email

Past Companies

VitriVaxHead of Product Research and Development
VitriVaxSenior Scientist, Formulation Development
Azurity PharmaceuticalsAssociate Principal Scientist

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.